The federal government’s plan to push patented drug prices lower continues to meet with controversy. The changes to the regulations governing the Patented Medicine Prices Review Board (PMPRB) have aroused criticism from patient groups and the pharmaceutical industry, which are concerned that the changes will result in fewer life-saving drugs being available in Canada. Rather than being open to dissenting voices and facilitating a constructive
The Brain Tumour Registry of Canada (BTRC) published their Incidence and Mortality Report on May 26th, 2021. The detailed breakdown of the data and the inclusion of non-malignant tumours make this report uniquely valuable compared to other reporting on brain tumours.
Canada’s drug review and reimbursement systems are already onerous. It can take from two to five years for some drugs to get to patients. The speed with which we have introduced COVID vaccines shows our government can do much better. Protect our Access is advocating for millions of patients across Canada whose lives depend on medical breakthroughs. READ AND SHARE their recent editorial in Ottawa Citizen
55% of Canadian cancer patients, caregivers and those awaiting confirmation of a cancer diagnosis have had appointments, tests, and treatment postponed or cancelled. Half of all Canadians will become cancer patients. We need a plan for their care during the next national crisis because Cancer Can’t Wait. Read our open letter in The Globe and Mail and Le Devoir this World Cancer Day. Read the
Virtual appointments with your doctor including video calls, phone calls, text messages and emails have been the new norm ever since the start of Covid-19. However, this method of contact has a major impact on a patient’s ability to effectively communicate their symptoms and concerns. According to our Leger survey on the Impact of COVID-19 Crisis on Cancer Patients and their Ability to Receive Treatment
Today marks World Cancer Day. Health experts detail the impact of COVID-19 on cancer treatment delays here in Ontario. And a Leger Survey from the Canadian Cancer Survivor Network reflects the impact that these delays in treatment have on patients’ mental health. Click here to access the podcast.